Enveric Biosciences Inc — Quarterly Financial Statistics (NASDAQ:ENVB) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics

Quarterly Annual

Cash from operating activities -927.07 K-1.31 M-2.39 M-1.89 M-2.07 M -7.67 M Cash from investing activities 00——— — Cash from financing activities 517.69 K463.45 K4.45 M449.1 K2.99 M 8.35 M Free cash flow -927.07 K-1.31 M-2.39 M-1.89 M-2.07 M -7.67 M

Nachrichten

Gilgamesh Withdraws Patent Fight Against Enveric After $1.2 Billion AbbVie Deal, CEO Says Key Drug Claims Now Uncontested - Enveric Biosciences (NASDAQ:ENVB)

Neue Studiendaten zu EB-003 beflügeln Aktie von Enveric Biosciences

Enveric Biosciences stock soars after revealing new data on lead drug candidate

Enverics führender Medikamentenkandidat aktiviert Schlüssel-Signalwege zur Linderung von Depressionen

Enveric’s lead drug candidate activates key pathways linked to depression relief

Enveric Advances Lead Drug With New Findings On Key Brain Receptor Signals - Enveric Biosciences (NASDAQ:ENVB)

Enveric Biosciences registriert neue Aktien im Wert von 1,35 Mio. US-Dollar im Rahmen einer ATM-Vereinbarung

Enveric Biosciences registers $1.35 million in new shares under ATM agreement

Enveric licenses RCANN trademark portfolio to TOTEC Pharma

Enveric Biosciences schließt Direktplatzierung über 1,5 Millionen US-Dollar ab

Enveric Biosciences closes $1.5 million registered direct offering

Enveric Biosciences raises $1.5 million in registered direct offering